Drug intelligence / Profile preview

TA-65MD

Development stage
Unknown
Lead developer
TA Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

TA-65MD is a dietary supplement and medical food formulation containing a proprietary small molecule telomerase activator originally isolated from traditional Chinese medicine extracts, most notably from *Astragalus membranaceus*. It is designed to **activate telomerase**, the enzyme that maintains and elongates telomeres—the protective caps at the ends of chromosomes implicated in cellular aging. Clinical studies have investigated TA-65MD in various populations, particularly older adults and those with cardiovascular disease, showing it may increase telomere length, support immune cell counts, and reduce laboratory markers of inflammation. The mechanism of action, while not fully elucidated, centers on **activation of telomerase** in immune cells, potentially leading to healthier cellular aging and improved adaptive immunity[1][2][3][4][5][6][7]. TA-65MD is sold as a dietary supplement, is manufactured to cGMP standards, and has a generally recognized as safe (GRAS) designation. Most data come from phase II studies for cardiovascular disease.

Brand names
TA-65MDTA65MDTA 65MDTA-65TA65TA 65
Other names
TA-65MDTA65MDTA 65MDTA-65TA65TA 65
02

Targets

TERT (Telomerase)

Beyond the preview

Go deeper on TA-65MD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TA-65MD.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call